224 research outputs found
3D Radiative Transfer in Carinae: Application of the SimpleX Algorithm to 3D SPH Simulations of Binary Colliding Winds
Eta Carinae is an ideal astrophysical laboratory for studying massive binary
interactions and evolution, and stellar wind-wind collisions. Recent
three-dimensional (3D) simulations set the stage for understanding the highly
complex 3D flows in Car. Observations of different broad high- and
low-ionization forbidden emission lines provide an excellent tool to constrain
the orientation of the system, the primary's mass-loss rate, and the ionizing
flux of the hot secondary. In this work we present the first steps towards
generating synthetic observations to compare with available and future HST/STIS
data. We present initial results from full 3D radiative transfer simulations of
the interacting winds in Car. We use the SimpleX algorithm to
post-process the output from 3D SPH simulations and obtain the ionization
fractions of hydrogen and helium assuming three different mass-loss rates for
the primary star. The resultant ionization maps of both species constrain the
regions where the observed forbidden emission lines can form. Including
collisional ionization is necessary to achieve a better description of the
ionization states, especially in the areas shielded from the secondary's
radiation. We find that reducing the primary's mass-loss rate increases the
volume of ionized gas, creating larger areas where the forbidden emission lines
can form. We conclude that post processing 3D SPH data with SimpleX is a viable
tool to create ionization maps for Car.Comment: 18 pages, 11 figures, accepted for publication in MNRA
Connecting the dots : analysis, development and applications of the SimpleX algorithm
The SimpleX radiative transfer method is based on the interpretation of photons as particles interacting on a natural scale: the local mean free path. In our method, light is transported along the lines of an unstructured Delaunay mesh that encodes this natural distance and represents the physical medium. The SimpleX method is fast, highly adaptive and its computational cost does not scale with the number of sources. It is therefore well-suited for cosmological applications where it is essential to cover many orders of magnitude in resolution and where millions of sources can exist within a single simulation. We describe the code, its recent developments and apply it to several relevant astrophysical problems. In particular, we perform radiative transfer calculations of cosmological reionization and of the wind-wind interaction region of the Eta Carinae binary system.UBL - phd migration 201
Estimating incidence of venous thromboembolism in COVID-19:Methodological considerations
Background Coagulation abnormalities and coagulopathy are recognized as consequences of severe acute respiratory syndrome coronavirus 2 infection and the resulting coronavirus disease 2019 (COVID-19). Specifically, venous thromboembolism (VTE) has been reported as a frequent complication. By May 27, 2021, at least 93 original studies and 25 meta-analyses investigating VTE incidence in patients with COVID-19 had been published, showing large heterogeneity in reported VTE incidence ranging from 0% to 85%. This large variation complicates interpretation of individual study results as well as comparisons across studies, for example, to investigate changes in incidence over time, compare subgroups, and perform meta-analyses. Objectives This study sets out to provide an overview of sources of heterogeneity in VTE incidence studies in patients with COVID-19, illustrated using examples. Methods The original studies of three meta-analyses were screened and a list of sources of heterogeneity that may explain observed heterogeneity across studies was composed. Results The sources of heterogeneity in VTE incidence were classified as clinical sources and methodologic sources. Clinical sources of heterogeneity include differences between studies regarding patient characteristics that affect baseline VTE risk and protocols used for VTE testing. Methodologic sources of heterogeneity include differences in VTE inclusion types, data quality, and the methods used for data analysis. Conclusions To appreciate reported estimates of VTE incidence in patients with COVID-19 in relation to its etiology, prevention, and treatment, researchers should unambiguously report about possible clinical and methodological sources of heterogeneity in those estimates. This article provides suggestions for that.Thrombosis and Hemostasi
Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020
This population-based cohort study aimed to describe changes in incidence of cardiovascular disease (CVD) hospital diagnoses during the COVID-19 pandemic in The Netherlands compared with the pre-pandemic period. We used Dutch nationwide statistics about hospitalizations to estimate incidence rate ratios (IRR) of hospital diagnoses of CVD during the first and second COVID-19 waves in The Netherlands in 2020 versus the same periods in 2019. Compared with 2019, the incidence rate of a hospital diagnosis of ischemic stroke (IRR 0.87; 95% CI 0.79-0.95), major bleeding (IRR 0.74; 95% CI 0.68-0.82), atrial fibrillation (IRR 0.73; 95% CI 0.65-0.82), myocardial infarction (IRR 0.78; 95% CI 0.72-0.84), and heart failure (IRR 0.74; 95% CI 0.65-0.85) declined during the first wave, but returned to pre-pandemic levels throughout 2020. However, the incidence rate of a hospital diagnosis of pulmonary embolism (PE) increased during both the first and second wave in 2020 compared with 2019 (IRR 1.30; 95% CI 1.15-1.48 and IRR 1.31; 95% CI 1.19-1.44, respectively). In conclusion, we observed substantial declines in incidences of CVD during the COVID-19 pandemic in The Netherlands in 2020, especially during the first wave, with an exception for an increase in incidence of PE. This study contributes to quantifying the collateral damage of the COVID-19 pandemic.</p
Levels of Fibrinogen Variants Are Altered in Severe COVID-19
Background  Fibrinogen variants as a result of alternative messenger RNA splicing or protein degradation can affect fibrin(ogen) functions. The levels of these variants might be altered during coronavirus disease 2019 (COVID-19), potentially affecting disease severity or the thrombosis risk. Aim  To investigate the levels of fibrinogen variants in plasma of patients with COVID-19. Methods  In this case-control study, we measured levels of functional fibrinogen using the Clauss assay. Enzyme-linked immunosorbent assays were used to measure antigen levels of total, intact (nondegraded Aα chain), extended Aα chain (α E ), and γ' fibrinogen in healthy controls, patients with pneumococcal infection in the intensive care unit (ICU), ward patients with COVID-19, and ICU patients with COVID-19 (with and without thrombosis, two time points). Results  Healthy controls and ward patients with COVID-19 ( n  = 10) showed similar fibrinogen (variant) levels. ICU patients with COVID-19 who later did ( n  = 19) or did not develop thrombosis ( n  = 18) and ICU patients with pneumococcal infection ( n  = 6) had higher absolute levels of functional, total, intact, and α E fibrinogen than healthy controls ( n  = 7). The relative α E fibrinogen levels were higher in ICU patients with COVID-19 than in healthy controls, while relative γ' fibrinogen levels were lower. After diagnosis of thrombosis, only the functional fibrinogen levels were higher in ICU patients with COVID-19 and thrombosis than in those without, while no differences were observed in the other fibrinogen variants. Conclusion  Our results show that severe COVID-19 is associated with increased levels of α E fibrinogen and decreased relative levels of γ' fibrinogen, which may be a cause or consequence of severe disease, but this is not associated with the development of thrombosis.</p
Levels of Fibrinogen Variants Are Altered in Severe COVID-19
Background  Fibrinogen variants as a result of alternative messenger RNA splicing or protein degradation can affect fibrin(ogen) functions. The levels of these variants might be altered during coronavirus disease 2019 (COVID-19), potentially affecting disease severity or the thrombosis risk. Aim  To investigate the levels of fibrinogen variants in plasma of patients with COVID-19. Methods  In this case-control study, we measured levels of functional fibrinogen using the Clauss assay. Enzyme-linked immunosorbent assays were used to measure antigen levels of total, intact (nondegraded Aα chain), extended Aα chain (α E ), and γ' fibrinogen in healthy controls, patients with pneumococcal infection in the intensive care unit (ICU), ward patients with COVID-19, and ICU patients with COVID-19 (with and without thrombosis, two time points). Results  Healthy controls and ward patients with COVID-19 ( n  = 10) showed similar fibrinogen (variant) levels. ICU patients with COVID-19 who later did ( n  = 19) or did not develop thrombosis ( n  = 18) and ICU patients with pneumococcal infection ( n  = 6) had higher absolute levels of functional, total, intact, and α E fibrinogen than healthy controls ( n  = 7). The relative α E fibrinogen levels were higher in ICU patients with COVID-19 than in healthy controls, while relative γ' fibrinogen levels were lower. After diagnosis of thrombosis, only the functional fibrinogen levels were higher in ICU patients with COVID-19 and thrombosis than in those without, while no differences were observed in the other fibrinogen variants. Conclusion  Our results show that severe COVID-19 is associated with increased levels of α E fibrinogen and decreased relative levels of γ' fibrinogen, which may be a cause or consequence of severe disease, but this is not associated with the development of thrombosis.</p
Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients
Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare but severe complication following COVID-19 vaccination, marked by thrombocytopenia and thrombosis. Analogous to heparin-induced thrombocytopenia (HIT), VITT shares similarities in anti-platelet factor 4 (PF4) IgG-mediated platelet activation via the FcγRIIa. To investigate the involvement of platelet-antibodies in VITT, we analyzed the presence of platelet-antibodies directed against glycoproteins (GP)IIb/IIIa, GPV and GPIb/IX in the serum of 232 clinically suspected VITT patients determined based on (suspicion of) occurrence of thrombocytopenia and/or thrombosis in relation to COVID-19 vaccination. We found that 19% of clinically suspected VITT patients tested positive for anti-platelet GPs: 39%, 32% and 86% patients tested positive for GPIIb/IIIa, GPV and GPIb/IX, respectively. No HIT-like VITT patients (with thrombocytopenia and thrombosis) tested positive for platelet-antibodies. Therefore, it seems unlikely that platelet-antibodies play a role in HIT-like anti-PF4-mediated VITT. Platelet-antibodies were predominantly associated with the occurrence of thrombocytopenia. We found no association between the type of vaccination (adenoviral vector vaccine versus mRNA vaccine) or different vaccines (ChAdOx1 nCoV-19, Ad26.COV2.S, mRNA-1273, BTN162b2) and the development of platelet-antibodies. It is essential to conduct more research on the pathophysiology of VITT, to improve diagnostic approaches and identify preventive and therapeutic strategies.</p
The escape of ionising radiation from high-redshift dwarf galaxies
The UV escape fraction from high-redshift galaxies plays a key role in models
of cosmic reionisation. Because it is currently not possible to deduce the
escape fractions during the epoch of reionisation from observations, we have to
rely on numerical simulations. Our aim is to better constrain the escape
fraction from high-redshift dwarf galaxies, as these are the most likely
sources responsible for reionising the Universe. We employ a N-body/SPH method
that includes realistic prescriptions for the physical processes that are
important for the evolution of dwarf galaxies. These models are post-processed
with radiative transfer to determine the escape fraction of ionising radiation.
We perform a parameter study to assess the influence of the spin parameter, gas
fraction and formation redshift of the galaxy and study the importance of
numerical parameters as resolution, source distribution and local gas clearing.
We find that the UV escape fraction from high-redshift dwarf galaxies that have
formed a rotationally supported disc lie between 1e-5 and 0.1. The mass and
angular momentum of the galaxy are the most important parameters that determine
the escape fraction. We compare our results to previous work and discuss the
uncertainties of our models. The low escape fraction we find for high-redshift
dwarf galaxies is balanced by their high stellar content, resulting in an
efficiency parameter for stars that is only marginally lower than the values
found by semi-analytic models of reionisation. We therefore conclude that dwarf
galaxies play an important role in cosmic reionisation also after the initial
starburst phase, when the gas has settled into a disc.Comment: 19 pages, 14 figures. Accepted for publication in A&
- …